Paciente varón de tres años con sibilancias y tos crónica / Three-Year-Old Male with Wheezing and Chronic Cough

Se presenta el caso de un niño de 3 años con diagnóstico de asma, rinitis alérgica, características craneofaciales dismórficas e infecciones respiratorias altas y bajas recurrentes, manejado como asma desde un inicio. Como parte del estudio de comorbilidades, se decide realizar una prueba del sudor que sale en rango intermedio y más tarde se encuentra una mutación, donde se obtiene un resultado positivo para una copia que se asocia a fibrosis quística. Se revisará el caso, así como el diagnóstico, clínica y tratamiento del síndrome metabólico relacionado con el regulador de conductancia transmembrana de fibrosis quística (CRMS).

We present the case of a 3-year-old boy with a diagnosis of asthma, allergic rhinitis, dysmorphic craniofacial characteristics and recurrent upper and lower respiratory infections, managed as asthma from the beginning. As part of the study of comorbidi-ties, it was decided to carry out a sweat test that came out in the intermediate range and later one mutation was found, where a positive result was obtained for a copy that is associated with cystic fibrosis. The case will be reviewed, as well as the diagnosis, symptoms and treatment of the metabolic syndrome related to the cystic fibrosis trans-membrane conductance regulator (CRMS).

Expressão de microRNA no plasma e suas relações com biomarcadores cardiometabólicos e dieta em idosos participantes de estudo de base populacional (ISA Capital) / Plasma microRNA expression and its associations with cardiometabolic biomarkers, and diet in elderly participants of a population-based study (ISA Capital)

Introdução - O desenvolvimento das doenças crônicas não transmissíveis (DCNT) em idosos está relacionado, dentre outros fatores, à desregulação da expressão de microRNAs (miRNAs), a qual pode ser modulada por fatores ambientais, incluindo o padrão alimentar. Objetivo - Avaliar o perfil de expressão plasmática de miRNAs e suas relações com biomarcadores cardiometabólicos e dieta em idosos do estudo de base populacional ISA Capital. Métodos - Estudo transversal, com subamostra de 200 indivíduos idosos participantes do ISA Nutrição. Foi avaliado o perfil de expressão de 21 miRNAs plasmáticos. Os indivíduos foram avaliados quanto às medidas antropométricas e à pressão arterial sistêmica; biomarcadores glicêmicos, do perfil lipídico e inflamatórios; e ao consumo alimentar. Calculou-se o escore de inflamação crônica e de baixo grau (SIS) a partir das concentrações de 10 biomarcadores inflamatórios. A expressão plasmática dos miRNAs circulantes foi analisada a partir do método Fluidigm. Os indivíduos avaliados foram distribuídos em dois grupos de acordo com a presença ou não de síndrome metabólica (SM), e o teste ajustado de Wald foi utilizado para comparar a expressão dos miRNAs entre os grupos. A partir do coeficiente tau-a de Kendall estimou-se as correlações entre a expressão dos miRNAs e variáveis de interesse. O teste de Wilcoxon-Mann-Whitney foi utilizado para determinar as diferenças no SIS em indivíduos de acordo com o sexo e a presença de SM. O teste de correlação de Spearman estimou as correlações entre o SIS, concentrações de leptina, miRNAs e demais variáveis de interesse. Além disso, utilizou-se modelos lineares generalizados (MLGs) para aprofundar as associações encontradas. As análises foram realizadas nos softwares Stata/SE (versão 17.0) e R (versão 4.2.3), considerando nível de significância de 0,05. Resultados - A amostra final deste estudo consistiu em 193 indivíduos (69,1 (0,5) anos), sendo 50,4% do sexo feminino, e 64,7% com SM. A expressão plasmática dos miR-30a e miR-122 foi maior em indivíduos com SM do que naqueles sem SM, e sua expressão se correlacionou à glicemia e insulinemia em jejum, HOMA1-IR, HDL-c, VLDL-c, LDL-c, colesterol não-HDL e triacilgliceróis. Além disso, associações negativas entre cinco miRNAs (miR-15a, miR-16, miR-223, miR-363, miR-532), concentração de leptina e/ou SIS foram observadas. Ainda, o consumo de diversos grupos alimentares influenciou a expressão plasmática dos miRNAs. O consumo diário de 100 g de frutas se relacionou à redução na expressão dos miR-16, miR-30a, miR-126, miR-130b, miR-363, miR-375, miR-486 e miR-532. Contudo, o consumo de carne vermelha se associou ao aumento na expressão plasmática de quatro miRNAs (miR-126, miR-150, miR-223 e miR-376a). Ainda, observou-se que o consumo diário de 100 g de hortaliças se associou a uma chance 7 vezes maior de os indivíduos avaliados não apresentarem SM. Conclusões - O aumento da expressão plasmática dos miR-21, miR-30a e miR-122 sugere maior risco cardiometabólico, ao passo que a redução na expressão dos miR-15a, miR-16, miR-223, miR-363 e miR-532 sugere menor risco cardiometabólico em idosos. Ainda, os resultados encontrados enfatizam a importância da adoção de hábitos alimentares saudáveis na regulação da expressão dos miRNAs e, consequentemente, na redução do risco de desenvolvimento de DCNT.

Introduction: The development of noncommunicable diseases (NCD) in older adults is related, among other factors, to the dysregulation of microRNAs (miRNAs) expression, which can be modulated by environmental factors, including dietary patterns. Objectives: To assess the plasma expression profile of miRNAs and its relationships with cardiometabolic biomarkers and diet of older adults participating in the ISA Capital population-based study. Methods: Cross-sectional study, with a sub-sample of 200 older adults participating in ISA Nutrition. The expression profile of 21 plasma miRNAs was evaluated. Subjects were evaluated for anthropometric measurements and systemic blood pressure; glycemic, lipid and inflammatory biomarkers; and food consumption. Furthermore, the chronic and low-grade inflammation score (SIS) was calculated based on the concentrations of 10 inflammatory biomarkers. The plasma expression of circulating miRNAs was analyzed using the Fluidigm method. The evaluated individuals were distributed into two groups according to the presence or absence of metabolic syndrome (MetS), and the adjusted Wald test was used to compare the expression of miRNAs between the groups. Using Kendall's tau-a coefficient, correlations between miRNAs expression and variables of interest were estimated. The Wilcoxon-Mann-Whitney test was used to determine differences in SIS based on the distribution of individuals according to sex and the presence of MetS. The Spearman correlation test estimated correlations between SIS, leptin concentrations, miRNAs and other variables of interest. Furthermore, generalized linear models were used to deepen the associations found. All analyzes were performed using Stata/SE (version 17.0) and R (version 4.2.3) software, considering a significance level of 0.05. Results: The final sample of this study consisted of 193 individuals, (69.1 (0.5) years), 50.4% of whom were female, and 64.7% with MetS. Plasma expression of miR-30a and miR-122 was higher in individuals with MetS than in those without MetS, and their expression correlated with fasting glycemia and insulinemia, HOMA1-IR, HDL-c, VLDL-c, LDL-c, non-HDL cholesterol and triacylglycerols. Furthermore, negative associations between five miRNAs (miR-15a, miR-16, miR-223, miR-363, miR-532), leptin concentration and/or SIS were observed. In addition, the consumption of different food groups influenced the plasma expression of miRNAs. Daily consumption of 100 g of fruits was related to a reduction in the expression of miR-16, miR-30a, miR-126, miR-130b, miR-363, miR-375, miR-486, miR-532. On the other hand, red meat consumption was associated with an increase in the plasma expression of four miRNAs (miR-126, miR-150, miR-223 and miR-376a). Furthermore, it was observed that the daily consumption of 100 g of vegetables was associated with a 7 times greater chance of the individuals evaluated not having MetS. Conclusions: The increase in the plasma expression of miR-21, miR-30a and miR-122 suggests a greater cardiometabolic risk, while the reduction in the expression of miR-15a, miR-16, miR-223, miR-363 and miR-532 suggests lower cardiometabolic risk in the elderly. Furthermore, the results found emphasize the importance of adopting healthy eating habits in regulating the expression of miRNAs and, consequently, in reducing the risk of developing NCD.

Experiencias infantiles adversas y síndrome metabólico en adultos de una unidad de medicina familiar en Michoacán, México / Adverse childhood experiences and metabolic syndrome in adults in a family medicine unit Michoacán, Mexico

Introducción: las experiencias infantiles adversas (EIA) aumentan el riesgo de enfermedades metabólicas en la edad adulta; no obstante, esta relación ha sido poco estudiada en la población mexicana Objetivos: determinar la frecuencia de experiencias infantiles adversas (EIA) y su relación con el síndrome metabólico en personas mayores de 19 años de edad en una unidad de medicina familiar urbana en Michoacán, México. Metodología: se realizó un estudio observacional, retrospectivo, transversal y analítico en 127 participantes mayores de 19 años. Se evaluaron sus medidas antropométricas, y cuantificamos los niveles de glucosa en ayuno, triglicéridos y colesterol HDL en sangre. Aplicamos el cuestionario internacional de experiencias infantiles adversas (ACE-IQ). Utilizamos estadística descriptiva y la prueba de Chi cuadrada. Resultados: el 95% de la muestra reportó al menos una EIA, y la más frecuente fue la violencia doméstica. El 45% de los individuos presentaron síndrome metabólico. No se encontró asociación entre el síndrome metabólico ni los componentes con la exposición a las EIA. No obstante, observamos que el divorcio o pérdida de uno de los padres fue más frecuente en los participantes con síndrome metabólico (p = 0.03). Conclusiones: la frecuencia de EIA fue mucho más alta que lo previamente reportado, pero no se observó una asociación con el síndrome metabólico... (AU)

Introduction: Adverse childhood experiences (ACE) increase the risk of metabolic diseases in adulthood; however, this relationship has been scarcely studied in the Mexican population. Objective: To determine the frequency of adverse childhood experiences and their relationship to metabolic syndrome in an urban Primary Care Unit from Michoacán, México. Methods: An observational, retrospective, cross-sectional and analytical study was performed in 127 participants older than 19 years. Their anthropometric measurements were evaluated, and we quantified the blood levels of fasting glucose, triglycerides, and HDL cholesterol. The Adverse Childhood Experiences International Questionnaire (ACE-IQ) was utilized. We used descriptive statistics and the Chi square test. Results: 95% of the sample reported at least one EIA, and the most frequent was domestic violence. 45% of individuals presented metabolic syndrome. No association was found between the metabolic syndrome or its components with the exposure to EIA. However, we observed that divorce or loss of one of the parents was more frequent in the participants with metabolic syndrome (p = 0.03). Conclusions: The frequency of EIA was much higher than previously reported, however, we did not observe an association of ACE with metabolic... (AU)

Repercusión del síndrome metabólico sobre el crecimiento de fetos de ratas Wistar / Repercussion of the metabolic syndrome on the growth of Wistar rat fetuses

Introducción: El síndrome metabólico es un conjunto de anomalías metabólicas como obesidad, dislipidemia, intolerancia a la glucosa e hipertensión arterial. Se realizó estudio experimental, longitudinal prospectivo en la Unidad de Toxicología Experimental de Villa Clara, periodo septiembre del 2016 y julio del 2019. Objetivo: Evaluar las modificaciones del crecimiento de los fetos de ratas con síndrome metabólico, con respecto al grupo control. Métodos: Se crearon dos grupos, uno de control y otro de estudio con síndrome metabólico inducido. Las variables estudiadas fueron: peso, talla y diámetros craneanos. Se utilizó el programa Excel 2010 y el SPSS versión 15.0 para Windows, la prueba Chi Cuadrado, y como estadístico de decisión, la significación de Monte Carlo. Resultados: Los fetos de ratas con síndrome metabólico inducido tuvieron mayor peso y talla. Conclusiones: El síndrome metabólico influyó en la ganancia del peso y la talla en los fetos en vida prenatal, al incrementar la probabilidad de macrosomía al momento del nacimiento.

Introduction: metabolic syndrome is a group of metabolic abnormalities such as obesity, dyslipidemia, glucose intolerance and arterial hypertension. An experimental, longitudinal and prospective study was carried out in the Villa Clara Experimental Toxicology Unit from September 2016 to July 2019. Objective: to evaluate the changes in the growth of rat fetuses with metabolic syndrome, with respect to the control group. Methods: two groups with induced metabolic syndrome were created, one for control and the other for study. Weight, height and cranial diameters were the studied variables. The Excel 2010 program and SPSS version 15.0 for Windows and the Chi Square test were used, as well as the Monte Carlo significance as statistical decision. Results: rat fetuses with induced metabolic syndrome had greater weight and height. Conclusions: the metabolic syndrome influenced the weight and height gain in prenatal fetuses, increasing the probability of macrosomia at birth.

Índices de fibrosis en el seguimiento de la enfermedad hepática grasa no alcohólica / Fibrosis indices in non-alcoholic fatty liver disease follow-up

Introducción: La enfermedad hepática grasa no alcohólica es una afección clínica- morfológica que se caracteriza por una infiltración grasa del hígado en más de un 5 %; tiene dos estadios: esteatosis simple y esteatohepatitis, la cual puede progresar a: fibrosis, cirrosis y hepatocarcinoma. Objetivo: Determinar la relación entre las variables clínicas y epidemiológicas con esta enfermedad, así como los índices de fibrosis y su relación. Métodos: Se realizó un estudio descriptivo con diseño transversal en los pacientes atendidos en la consulta de hígado y vías biliares del Hospital Universitario « Dr. Celestino Hernández Robau», en la etapa de enero- diciembre de 2017. Se trabajó con una población conformada por 60 pacientes, mayores o igual a 20 años de edad, con diagnóstico de enfermedad hepática grasa no alcohólica primaria, sobrepesos u obesos. Resultados: Predominó el grupo etario entre 50-59 años de edad, del sexo femenino, obesos y con esteatosis grado I. Se constató que el 73,33% de los pacientes tenían síndrome metabólico y en ellos prevaleció el grado II de esteatosis. Al relacionar los riesgos de fibrosis se encontraron 28 pacientes con riesgo indeterminado y alto en las clasificaciones FIB-4 y NFS, respectivamente, y 5 presentaron alto riesgo en ambas variables. Los índices de FIB-4 y NFS tuvieron una correlación significativa, directamente proporcional y considerable. Conclusiones: La correlación detectada entre los índices FIB-4 y NFS reafirmó el valor en la detección de sospecha de fibrosis y orientó, en la práctica clínica, la conducta ante los diferentes pacientes con esta afección.

Introduction: non-alcoholic fatty liver disease is a clinical and morphological condition characterized by fatty infiltration of the liver in more than 5%; it has two stages: simple steatosis and steatohepatitis, which can progress to fibrosis, cirrhosis and hepatocellular carcinoma. Objective: to determine the relationship between clinical and epidemiological variables with this disease, as well as fibrosis indices and their relationship. Methods: a cross-sectional descriptive study was carried out in patients seen in the liver and biliary tract consultation at " Dr. Celestino Hernández Robau" University Hospital from January to December 2017. We worked with a population made up of 60 overweight or obese patients older than or equal to 20 years who were diagnosed with primary non-alcoholic fatty liver disease. Results: the age group between 50-59 years of age, female gender, obese ones and with grade I steatosis prevailed. We found that 73.33% of the patients had metabolic syndrome and grade II steatosis prevailed in them. A number of 28 patients were found with indeterminate and high risk in the FIB-4 and NAFLD classifications, respectively, when relating the risks of fibrosis, as well as 5 had high risk in both variables. The FIB-4 and NAFLD indices had a significant, directly proportional, and considerable correlation. Conclusions: the correlation detected between the FIB-4 and NAFLD indices reaffirmed the value in the detection of suspected fibrosis and guided, in clinical practice, the conduct of different patients with this condition.

Asociación entre el síndrome metabólico y el cáncer de mama en mujeres posmenopáusicas: Un estudio observacional de centro único / Association between metabolic syndrome and breast cancer in postmenopausal women: A single-center observational study

Introducción: El factor de riesgo más importante para el desarrollo del síndrome metabólico (SM) es la obesidad, un estado pro inflamatorio con alteraciones sistémicas y locales vinculadas al crecimiento tumoral, siendo un determinante en el desarrollo del cáncer de mama en la posmenopausia, en su pronóstico y en la eficacia del tratamiento. El objetivo del presente estudio fue determinar la asociación entre el SM y el Cáncer de Mama en mujeres posmenopáusicas comparradas con un grupo control. Materiales y métodos: El estudio fue de diseño observacional, analítico; se llevó a cabo en el Hospital de SOLCA-Guayaquil entre enero a diciembre del 2019. El muestreo fue no probabilístico. Se incluyeron casos de mujeres de 50 ­ 70 años con patología de mama. Las variables fueron presencia de síndrome metabólico y diagnóstico de cáncer de mama en mujeres posmenopaúsicas. Se utilizó Chi cuadrado, Odds Ratio, el intervalo de confianza al 95 % y valor P < 0.05 para revisar la significancia estadística. Resultados: Ingresaron al estudio 157 casos, 107 en el grupo con cáncer de mama (G1) y 50 mujeres (31 %) sin patología maligna (G2). La edad en G1 fue de 59.9±9.9 años en G2 55.5±5.5 (P=0.001). El índice de masa corporal fue 29.05±1.2 en G1 y 26.80±1.3 en G2 (P<0.001). OR del SM para el desarrollo de Cáncer de mama fue 4.60 (IC 95% 2.23-9.51 ) P<0.0001. OR del SM para el desarrollo de cáncer de mama en mujeres menores a 54 años fue de 0.22 (0.069-0.72), P=0.0118. No hubo asociaciones por tipo histológico. Conclusión: Existe asociación entre el SM y el cáncer de mama en mujeres posmenopáusicas, por lo que se debe considerar la salud metabólica como un factor de riesgo clínicamente relevante y modificable para el desarrollo del cáncer.

Introduction: The most critical risk factor for developing metabolic syndrome (MS) is obesity, a pro-inflammatory state with systemic and local alterations linked to tumor growth. It is a determinant in developing postmenopausal breast cancer in its prognosis. and the efficacy of treatment. This study aimed to determine the association between MS and Breast Cancer in postmenopausal women compared to a control group. Materials and methods: The study had an observational, analytical design at the SOLCA-Guayaquil Hospital between January and December 2019. The sampling was non-probabilistic. Cases of women between 50 and 70 years of age with breast pathology were included. The variables were the presence of metabolic syndrome and diagnosis of breast cancer in postmenopausal women. Chi-square, Odds Ratio, 95% confidence interval, and P value < 0.05 were used to review statistical significance. Results: 157 cases entered the study, 107 in the group with breast cancer (G1) and 50 women (31%) without malignancy (G2). The age in G1 was 59.9±9.9 years in G2 55.5±5.5 (P=0.001). The body mass index was 29.05±1.2 in G1 and 26.80±1.3 in G2 (P<0.001). OR of the MS for the development of breast cancer was 4.60 (95% CI 2.23-9.51) P<0.0001. OR of the MS for the development of breast cancer in women under 54 years of age was 0.22 (0.069-0.72), P=0.0118. There were no associations by histological type. Conclusion: There is an association between MS and breast cancer in postmenopausal women, so metabolic health should be considered a clinically relevant and modifiable risk factor for cancer development.

Effect of clinical treatments for metabolic syndrome on albuminuria: a systematic review protocol

Introduction:Metabolic syndrome (MetS) predicts cardiovascular disease, and patients with this condition and type 2 diabetes have increased albuminuria, significantly impacting cardiovascular mortality and kidney disease progression. A considerable number of interventions to control MetS exist and are considered efficient, including the use of medication and changes in lifestyle. However, which approaches are effective in controlling albuminuria remains unclear. This systematic review protocol aims to map in the available literature whether lifestyle, medication, and surgical intervention for MetS have an impact on reducing albuminuria in adult patients. Methods: The Joanna Briggs Institute methodology for systematic reviews will be followed. Cochrane Database of Systematic Reviews, Scopus, Embase, and MEDLINE/PubMed databases will be used. For the Gray Literature, the DART-Europe E-theses Portal. There will be no language restriction. Studies written after 2009 will be included due to the consensus and definition of metabolic syndrome. This review will include studies considering pharmacological and non-pharmacological treatments for controlling albuminuria in patients with MetS. Studies where MetS is described in children and adolescents, animals, pregnant women, and patients with type 1 diabetes will be excluded. First, the selection will be based on reading the title and summary of the texts retrieved in the search strategy, followed by reading the relevant texts in full by two reviewers. After the selection of the studies, the extraction of the data, analysis, and synthesis will be conducted according to the JBI methodology

Riesgo de desarrollar diabetes mellitus tipo 2 según escala Finnish Diabetes Risk Score en atención primaria / Risk of Developing Type 2 Diabetes Mellitus According to the Finnish Diabetes Risk Score in Primary care

Introducción: La diabetes mellitus tipo 2, representa 90-95 por ciento de todas las diabetes, es una enfermedad crónica potencialmente prevenible, la escala Finnish Diabetes Risk Score es uno de los instrumentos más utilizados a nivel mundial para evaluar el riesgo de presentar diabetes en 10 años con enfoque fácil y económico. Objetivo: Determinar el riesgo de desarrollar diabetes en los próximos 10 años según escala Finnish Diabetes Risk Score en pacientes en una Unidad Médica Familiar de México. Métodos: Estudio transversal analítico, se aplicó la escala Finnish Diabetes Risk Score a 383 pacientes y se analizaron las variables implicadas en dicha escala, las variables edad e índice de masa corporal se describieron con medidas de tendencia central, las variables sexo, escolaridad, así como aquellas dicotómicas y de intervalo, mediante razones y proporciones. Se midió asociación mediante Odds Ratio para dicotómicas y coeficiente de Spearman para numéricas. Resultados: La mediana de edad fue de 47 años, predominó el sexo femenino, el 71,5 por ciento reportó sedentarismo, el 51,9 por ciento refirió un familiar de primer grado con diabetes, se determinó probabilidad del 67 por ciento de tener peso normal al realizar actividad física diaria; se determinó una probabilidad del 65 por ciento de presentar prediabetes si se tiene sobrepeso u obesidad, se determinó asociación lineal entre índice de masa corporal y edad, el riesgo predominante para desarrollar diabetes mellitus tipo 2 en 10 años fue alto. Conclusiones: El riesgo de desarrollar diabetes en 10 años en la población estudiada fue elevado y se relacionó con falta de actividad física, antecedentes familiares y sobrepeso(AU)

Introduction: Type 2 diabetes mellitus, accounts for 90-95 percent of all diabetes. It is a potentially preventable chronic disease. The Finnish Diabetes Risk Score is one of the most widely used instruments worldwide to assess the risk of developing diabetes in 10 years with an easy and inexpensive approach. Objective: To determine the risk of developing diabetes in the next 10 years according to the Finnish Diabetes Risk Score in patients in a Family Medical Unit in Mexico. Methods: Analytical cross-sectional study. The Finnish Diabetes Risk Score was applied to 383 patients and the variables involved in this scale were analyzed. The variables age and body mass index were described with measures of central tendency, while the variables gender, schooling, as well as dichotomous and interval variables, were described by ratios and proportions. Association was measured by Odds Ratio for dichotomous variables and Spearman's coefficient for numerical variables. Results: The average age was 47 years and female gender predominated. Sedentary lifestyle was reported by 71.5 percent and 51.9 percent reported a first-degree relative with diabetes. A 67percent probability of having a normal weight was determined when performing daily physical activity. In addition, a 65percent probability of having prediabetes was established if overweight or obese, and a linear association was found between body mass index and age. The predominant risk for developing type 2 diabetes mellitus in 10 years was high. Conclusions: The risk of developing diabetes in 10 years in the studied population was high and was related to lack of physical activity, family history and overweight(AU)

Relación del consumo de calcio con el síndrome metabólico en adultos de la Amazonía Ecuatoriana / Relationship of calcium consumption with metabolic syndrome in adults from the Ecuadorian Amazon

Introducción. El Síndrome Metabólico (SM) comprende un conjunto de factores de riesgo cardiometabólico representado por obesidad central, dislipidemia, hipertensión arterial y glucosa alterada, se ha evidenciado que el consumo adecuado de calcio representa una disminución del riesgo para este síndrome. Objetivo. Analizar la relación entre el consumo de calcio total, de origen animal y vegetal con el SM y sus indicadores. Materiales y métodos. Estudio transversal de eje correlacional, con una muestra de 100 adultos de la región amazónica ecuatoriana, durante el último trimestre del 2020. La ingesta dietética de calcio se determinó mediante un recordatorio de 24 horas y el SM según los criterios de Adult Treatment Panel-IV (ATP-IV). Resultados. La población estuvo conformada por adultos maduros (40 a 60 años) que evidenciaron una ingesta de calcio deficiente (182,50 mg y 228,60 mg en mujeres y hombres respectivamente). Se evidenció, además, una relación directamente proporcional entre la circunferencia abdominal (r=0,391 ­ p=0,000), presión arterial sistólica (r=0,290 ­ p=0,000) y glucosa en ayuno (r=0,326 ­ p=0,000) con la edad. La ingesta de calcio total se relacionó positivamente con los triglicéridos, (r=0,221 ­ p=0,027). Conclusiones. La ingesta dietética de calcio en ambos sexos no alcanza el requerimiento diario y se relaciona positivamente con los triglicéridos(AU)

Introduction. The Metabolic Syndrome (MS) comprises a set of cardiometabolic risk factors represented by central obesity, dyslipidemia, high blood pressure and altered glucose, it has been shown that adequate calcium intake represents a decreased risk for this syndrome. Objective. To analyze the relationship between the consumption of total calcium, animal and vegetable origin, with MS and its indicators. Materials and methods. Cross-sectional study of correlational axis, with a sample of 100 adults from the Ecuadorian Amazon region, during the last quarter of 2020. Dietary calcium intake was determined through a 24-hour recall and the diagnosis of MS according to the Adult Treatment Panel- IV (ATP-IV) criteria. Results. The population consisted of mature adults (40 to 60 years) who showed a deficient calcium intake in both sexes (182.50 mg and 228.60 mg in women and men respectively). There is also evidence of a directly proportional relationship between abdominal circumference (r=0.391 - p=0.000), systolic blood pressure (r=0.290 - p=0.000) and fasting glucose (r=0.326 - p=0.000) with age. Total calcium intake was positively related to triglycerides (r=0.221 ­ p=0.027). Conclusions. Calcium dietary intake in both sexes does not reach the daily requirement and is positively related to triglycerides(AU)

Compuestos bioactivos de canela y su efecto en la disminución del síndrome metabólico: revisión sistemática / Bioactive compounds of cinnamon and their effect on decreasing metabolic syndrome: systematic review

Introducción. El síndrome metabólico (SM) aumenta el ingreso hospitalario y el riesgo de desarrollar COVID-19, los fármacos utilizados para su tratamiento ocasionan efectos secundarios por lo que se ha optado por la búsqueda de alternativas terapéuticas a base de compuestos bioactivos contenidos en plantas medicinales. La canela se utiliza como agente terapéutico debido a sus propiedades comprobadas con diversos mecanismos de acción reportados en el tratamiento de varias patologías. Objetivo. Documentar los estudios in vitro, in vivo, estudios clínicos y los mecanismos de acción reportados del efecto de la administración de extractos y polvo de canela en las comorbilidades relacionadas con el SM. Materiales y métodos. Revisión sistemàtica de artículos en bases de datos electrónicas, incluyendo estudios de canela en polvo, extractos acuosos, de acetato de etilo y metanol de la corteza de canela, período de 5 años, excluyendo todo artículo relacionado a su efecto antimicrobiano, antifúngico y aceite de canela. Resultados. Las evidencias de los principales compuestos bioactivos contenidos en la canela validan su potencial en el tratamiento de enfermedades relacionadas al SM, con limitados estudios que indagan en los mecanismos de acción correspondientes a sus actividades biológicas. Conclusiones. Las evidencias de las investigaciones validan su potencial en el tratamiento de estas patologías, debido a sus principales compuestos bioactivos: cinamaldehído, transcinamaldehído, ácido cinámico, eugenol y, antioxidantes del tipo proantocianidinas A y flavonoides, los cuales participan en diversos mecanismos de acción que activan e inhiben enzimas, con efecto hipoglucemiante (quinasa y fosfatasa), antiobesogénico (UPC1), antiinflamatorio (NOS y COX), hipolipemiante (HMG-CoA) y antihipertensivo (ECA)(AU)

Introduction. Metabolic syndrome (MS) increases hospital admission and the risk of developing COVID-19. Due to the side effects caused by the drugs used for its treatment, the search for therapeutic alternatives based on bioactive compounds contained in medicinal plants has been chosen. Cinnamon is used as a therapeutic agent due to its proven properties with various mechanisms of action reported in the treatment of various pathologies. Objective. To document the in vitro and in vivo studies, clinical studies and the mechanisms of action reported on the effect of the administration of cinnamon extracts and powder on comorbidities related to MS. Materials and methods. Systematic review of articles in electronic databases, including studies of cinnamon powder, aqueous extracts, ethyl acetate and methanol from cinnamon bark, over a period of 5 years, excluding all those articles related to its antimicrobial, antifungal and antimicrobial effect. cinnamon oil. Results. The evidence of the main bioactive compounds contained in cinnamon validates its potential in the treatment of diseases related to MS, with limited studies that investigate the mechanisms of action corresponding to its biological activities. Conclusions. Research evidence validates its potential in the treatment of these pathologies, due to its main bioactive compounds: cinnamaldehyde, transcinnamaldehyde, cinnamic acid, eugenol, and antioxidants of the proanthocyanidin A type and flavonoids, which participate in various mechanisms of action that activate and they inhibit enzymes, with hypoglycemic (kinase and phosphatase), antiobesogenic (UPC1), anti-inflammatory (NOS and COX), lipid-lowering (HMG-CoA) and antihypertensive (ACE) effects(AU)

Síndrome metabólico en el adulto mayor vinculado a los programas de actividad física comunitaria / Metabolic Syndrome in the Elderly Adult Involved in the Community Physical Activity Programs

Introducción: El síndrome metabólico es una situación clínica compleja que se asocia a un incremento de la morbilidad y mortalidad. Los elementos que lo componen aumentan el riesgo de diabetes mellitus tipo II y enfermedad cardiovascular. Objetivo: Determinar el comportamiento del síndrome metabólico en el adulto mayor vinculado a los programas de actividad física comunitaria del proyecto Lindo Amanecer del municipio Arroyo Naranjo. Métodos: Se realizó un estudio observacional descriptivo de corte transversal. El universo de estudio lo constituyeron 120 adultos mayores, de los que se entrevistaron a 106, en el período de abril a octubre de 2018. Se siguieron los criterios del Adult Treatment Panel III para el diagnóstico de síndrome metabólico. Las variables descriptivas se expresaron en porcientos y para la comparación de variables en estudio se utilizó el método estadístico de ji al cuadrado. Resultados: Los resultados obtenidos mostraron un 41,51 por ciento de personas con síndrome metabólico, predominaron las personas de 70 y más años de edad (54,54 por ciento y el sexo femenino (93,18 por ciento). El 100 por ciento tuvieron cifras de presión arterial ≥ 130/85 mmHg. El 100 por ciento de los pacientes desconocían su enfermedad. Conclusiones: Se encontró predominio en los pacientes con síndrome metabólico del sexo femenino y del grupo de edad de 70 y más años. El diagnóstico a nivel de la Atención Primaria de Salud es deficiente. Se asocia a la hipertensión arterial, obesidad abdominal y al riesgo de enfermedad cardiovascular(AU)

Introduction: Metabolic syndrome is a complex clinical situation associated with an increase in morbidity and mortality. The elements that mark it up increase the risk of type 2 diabetes mellitus and cardiovascular disease. Objective: To determine the behavior of metabolic syndrome in elderly adults involved in the community physical activity programs of the Lindo Amanecer project in the municipality of Arroyo Naranjo. Methods: A cross-sectional descriptive observational study was carried out. The study universe was made up of 120 elderly adults, 106 of which were interviewed in the period from April to October 2018. The Adult Treatment Panel III criteria for the diagnosis of metabolic syndrome were followed. The descriptive variables were expressed in percentages and, for the comparison of variables under study, the chi-square statistical method was used. Results: The obtained results showed 41.51percent of people with metabolic syndrome, with a predominance of people aged 70 years and older (54.54percent) and the female sex (93.18percent). One hundred percent had blood pressure values over or equal to 130/85 mmHg. One hundred percent of the patients did not have any knowledge of their disease. Conclusions: In patients with metabolic syndrome, the predominance corresponded to the female sex, as well as the age group of 70 years and older. Diagnosis at the primary healthcare level is deficient. It is associated with arterial hypertension, abdominal obesity and the risk of cardiovascular disease(AU)

Prevalencia del síndrome metabólico en estudiantes del Campus San Lorenzo de la Universidad Nacional de Asunción / Prevalence of metabolic syndrome in students of the Campus San Lorenzo of the National University of Asunción

Introducción. El síndrome metabólico (SM) constituye una serie de desórdenes metabólicos que en conjunto son considerados factor de riesgo para desarrollar diabetes y enfermedad cardiovascular. Objetivo. Determinar la prevalencia del SM y sus componentes en estudiantes del campus San Lorenzo dela Universidad Nacional de Asunción en el periodo 2015-2016. Materiales y métodos. Estudio observacional descriptivo de corte transverso con un muestreo por conglomerados. Se incluyeron a 163 estudiantes de facultades o institutos seleccionados. Se aplicó un cuestionario para datos sociodemográficos y actividad física, y se realizaron mediciones de circunferencia de cintura(CC), peso y altura, además de niveles séricos en ayunas de glucosa, colesterol-HDLc y triglicéridos, conjuntamente con medición de presión arterial para determinar la presencia de SM según los criterios del Panel III (NCEP-ATP-III). Los datos fueron resguardados con estricta confidencialidad. Resultados.El50,92% de los participantes era del sexo masculino, con edad promedio de 21,6± 2,4 años. El 49,7% fueron considerados sedentarios,25,16% presentó sobrepeso, 8,59% obesidad,6,75% CCelevaday16,56% hipertensión. El 2,45% y 4,9% presenta ronglicemia basal y triglicérido elevados, respectivamente, y 37,42%HDL-c bajo. La prevalencia del SM fue del 4,91%,el 52,15 % presentó al menos un factor del NCEP-ATP-III para SM Conclusión. Alrededor de la mitad de los participantes presentó al menos un factor de riesgo de SM, y los componentes más frecuentes fueron la baja concentración de HDLc, y la hipertensión arterial. Se recomienda acciones preventivas en la población juvenil basadas en actividad física y alimentación saludable. Palabras Clave: síndrome metabólico; hipertensión; sobrepeso; adulto joven

Introduction: The metabolic syndrome (MS) constitutes of a series of metabolic disorders that together are considered a risk factor to develop diabetes and cardiovascular disease.Objective.To determine the prevalence of MS and its components in students of the National University of Asunción ­San Lorenzo Campusin the 2015-2016 period. Materials and Methods.Observational descriptive cross-sectional study with a cluster sampling. A total of 163 students from selected faculties or instituteswas included. A questionnaire was applied for sociodemographic data and physical activityandwaist circumference(WC), weight and height were measured, as well as fasting serum levels of Glucose, HDLc cholesterol and triglycerides, together with blood pressure to determine the presence of MS according to the Panel III criteria (NCEP-ATP-III). All data were kept strictly confidential. Results. 50,92% of participants were male, with a mean age of 21,6± 2,4 years.49.7% were considered sedentary,25,16% presented overweight, and 8,59% obesity, 16,56%hypertension. 6,75% presentedan elevated abdominal circumference,2,45% elevated basal glycemia, 4,9% elevated Triglycerides, 37,42% low HDLc.The prevalence of MS was 4,91%and52,15% presented at least one NCEP-ATP-III factor for MS. Conclusion. Aroundhalf of the participantspresented at least one risk factor for MS, the most frequent components were low HDLc concentration and arterial hypertension.It is recommendedpreventive actions in the youth population based on physical activity and healthy eating. Key words: metabolic syndrome; hypertension; overweight; young adult

Prevalência de síndrome metabólica em pacientes pós-transplante renal / Prevalence of metabolic syndrome in post-kidney transplantation patients

O desenvolvimento da síndrome metabólica após o transplante renal (TxR) é evidenciado na literatura e se caracteriza por alterações que conferem a redução da função do enxerto. Objetivo: O objetivo deste trabalho é descrever a prevalência da síndrome metabólica e identificar variáveis que se associam à síndrome metabólica em receptores de TxR tardio. Metodologia: Trata-se de um estudo transversal analítico realizado com pacientes receptores de TxR. Foram incluídos participantes com idade superior ou igual a 18 anos, receptores de TxR tardio em acompanhamento superior a 6 meses. A análise descritiva dos dados foi expressa por médias, desvio padrão, medianas e percentuais. A normalidade dos dados foi verificada pelo teste de Shapiro-Wilk ao nível de 5% de significância. Aplicou-se o teste de comparação de médias para duas amostras independentes, teste t de Student. Foi utilizado o teste de correlação de Pearson para avaliar as possíveis relações existentes entre a variável tempo pós TxR com as outras variáveis de interesse. Resultados: Ao avaliar 43 pacientes com idade média de 50,9 ± 9,8 anos, notou-se que a síndrome metabólica esteve presente em 53,85% dos voluntários e que se associou ao peso prévio (p= 0,018), concentrações séricas de triglicerídeos (p= 0,001), menores médias de HDL (p= 0,053) e, também, foi verificada uma associação marginal com a circunferência da cintura (p= 0,051). A SM foi prevalente no período pós TxR. Ainda, as maiores médias de peso prévio ao TxR, de circunferência da cintura, de triglicerídeos e as menores médias de HDL se associaram à SM

The onset of metabolic syndrome (MS) after kidney transplantation (KTx) is evidenced in the literature and this is characterized by alterations that confer a reduction in the function of the transplantation. Objective: The aim of this research is to describe the prevalence of the metabolic syndrome and to identify the variables that are associated with the metabolic syndrome in recipients of belated KTx. Methods: This is an analytical cross-sectional study carried out with patients receiving KTx. Participants aged 18 years or older, recipients of late KTx with follow-up longer than 6 months, were included. The descriptive analysis of the data was expressed as means, standard deviation, medians and percentages. Data normality was verified using the Shapiro-Wilk test at a 5% significance level. The mean comparison test was applied for two independent samples, Student's t test. Pearson's correlation test was used to assess possible association between the variable time after KTx and the other variables of interest. Results: Forty-three patients with a mean age of 50.9 ± 9.8 years were evaluated and metabolic syndrome was present in 53.85% of the volunteers. There was an association with previous weight (p= 0.018), serum triglyceride concentrations (p= 0.001) and lower HDL means (p= 0.053) and and a marginal association with waist circumference (p=0,0051). MS was prevalent in the post-KTx period. Furthermore, the highest means of weight prior to KTx, waist circumference, TG and the lowest means of HDL were associated with MS

Telas na infância: postagens de especialistas em grupos de cuidadores no facebook / Screens in childhood: posts of specialists in caretakers' groups in the facebook / Pantallas en la infancia: las publicaciones de expertos en grupos de cuidadores en facebook

Apesar das crescentes investigações sobre uso de telas na infância, essa é uma temática complexa e ainda recente, que traz diversos desafios para pesquisadores e cuidadores. Comunidades virtuais em redes sociais são utilizadas por mães e pais para esclarecer dúvidas e receber conselhos acerca da parentalidade e saúde infantil, podendo, simultaneamente, assumir uma função prescritiva e normativa quanto ao seu modo de agir. Sendo assim, este artigo pretende compreender como o uso de telas na infância vem sendo abordado por especialistas em grupos de mães e pais no Facebook. Foi realizado um estudo qualitativo envolvendo 49 postagens de especialistas, sobretudo psicólogos e educadores, extraídas de cinco grupos públicos de mães e pais nessa rede social. Os textos das publicações foram verificados por meio de análise temática e discutidos com base no referencial teórico psicanalítico. Os resultados mostraram que os especialistas destacam os possíveis prejuízos do uso de telas na infância, além de fornecer orientações aos pais sobre como lidar com sua presença no cotidiano das crianças e de suas famílias. Concluiu-se que apesar dos grupos de cuidadores no Facebook serem uma ferramenta de divulgação de informações acerca do uso de telas na infância, cabe não naturalizar a presença de especialistas nesses espaços virtuais criados por pais e mães, interpondo-se nos saberes e nas trocas horizontalizadas entre os cuidadores.(AU)

Although investigations on the use of screens in childhood are increasing, this is a complex and recent topic, which poses several challenges for researchers and caregivers. Virtual communities in social networks are used by mothers and fathers to clarify doubts and receive advice regarding parenting and child health, at times, simultaneously, assuming a prescriptive and normative role on their way of acting. Therefore, this study aimed to understand how the use of screens in childhood has been approached by experts in groups of mothers and fathers on Facebook. A qualitative study was carried out involving 49 posts from specialists, mainly psychologists and educators, extracted from five public groups of mothers and fathers in this social network. The publications' texts were verified via thematic analysis and discussed based on the psychoanalytical theoretical framework. The results showed that experts highlight the possible damage of the use of screens in childhood, in addition to providing guidance to parents on how to deal with the presence of digital technology in the daily lives of children and families. It was concluded that, although caregivers' groups on Facebook are a tool for disseminating information about the use of screens in childhood, it is important not to naturalize the presence of specialists in these virtual spaces created by fathers and mothers, interposing in the horizontally interchanges that occur between the caregivers.(AU)

A pesar de las crecientes investigaciones sobre el uso de pantallas en la infancia, este es un tema complejo y aún reciente, que plantea varios desafíos para investigadores y cuidadores. Las comunidades virtuales en las redes sociales son utilizadas por madres y padres para aclarar dudas y recibir consejos sobre educación y salud infantil, pudiendo, al mismo tiempo, asumir un rol prescriptivo y normativo sobre su forma de actuar. Por lo tanto, este estudio tuvo como objetivo comprender cómo el uso de las pantallas en la infancia ha sido abordado por especialistas en grupos de madres y padres en Facebook. Se realizó un estudio cualitativo a partir de 49 publicaciones de especialistas, principalmente de psicólogos y educadores, extraídas de cinco grupos públicos de madres y padres en esta red social. Se realizó en los textos de las publicaciones un análisis temático y se utilizó el marco teórico psicoanalítico. Los resultados mostraron que los expertos destacan posibles daños que provoca el uso de pantallas en la infancia, además de orientar a los padres sobre cómo afrontar esta presencia de la tecnología digital en el día a día de los niños y sus familias. Se concluyó que, a pesar de que los grupos de cuidadores en Facebook son una herramienta de difusión de información sobre el uso de pantallas en la infancia, es importante no naturalizar la presencia de especialistas en estos espacios virtuales creados por padres y madres que se interpone entre los saberes e intercambios horizontales de los cuidadores.(AU)

Efeitos da suplementação de óleo de abacate sobre o perfil lipídico e índices aterogênicos em intervenção duplo-cego e randomizada em pacientes com síndrome metabólica / Effects of avocado oil supplementation on lipid profile and atherogenic indices in a double-blind and randomised intervention in patients with metabolic syndrome

Introdução: A síndrome metabólica é definida como um conjunto de condições clínicas que acometem cerca de 25% da população mundial e 29,6% dos brasileiros. Essa síndrome está relacionada ao aumento dos desfechos cardiovasculares, que podem ser preditos através do perfil lipídico. Compostos bioativos, tais como os ácidos graxos monoinsaturados (MUFA), são fortes aliados na prevenção desses desfechos. Um alimento importante por conter compostos bioativos e MUFA em abundância é o abacate. Há, porém, poucos estudos avaliando o efeito do óleo puro/virgem de abacate sobre o perfil lipídico em humanos com síndrome metabólica, e seus efeitos sobre os índices aterogênicos inexistem. Objetivo: O estudo buscou avaliar a suplementação de óleo de abacate sobre os níveis lipídicos e índices aterogênicos em pacientes portadores de síndrome metabólica. Método: 31 indivíduos adultos e obesos foram randomizados em grupo controle (óleo de soja) e grupo intervenção (óleo de abacate). Estes foram avaliados nos períodos pré e pós-intervenção (12 semanas) através de anamnese clínica e avaliação nutricional. Resultados: Observou-se que tanto o grupo controle quanto o grupo intervenção tinham a ingestão de lipídeos e gordura saturada maior que o recomendável. Quanto ao perfil lipídico e índices aterogênicos, não foi observada diferença significativa entre os períodos pré e pós. Conclusão: Os resultados podem ter se dado pela ausência do controle alimentar, sobrecarga de medicamentos, duração da intervenção, modo de administração e dose do suplemento. Logo, são necessários estudos futuros sobre os efeitos do óleo de abacate nessa população, que controlem melhor essas variáveis.

Introduction: Metabolic syndrome is defined as a set of clinical conditions that affect approximately 25% of the world's population and 29.6% of Brazilians. This syndrome is related to increased cardiovascular outcomes, which may be predicted by the lipid profile. Bioactive compounds, such as monounsaturated fatty acids (MUFAs), are strong allies in preventing these outcomes. Avocado is an important food because it contains abundant bioactive compounds and MUFAs. However, few studies evaluated the effects of pure/virgin avocado oil on the lipid profile in humans with metabolic syndrome, and its effects on atherogenic indices are not known. Objective:This study evaluated avocado oil supplementation on lipid levels and atherogenic indices in patients with metabolic syndrome. Method: Thirty-one obese adults were randomised into a control group (soybean oil) and an intervention group (avocado oil). These groups were evaluated in the pre- and post-intervention periods (12 weeks) via clinical anamnesis and nutritional assessment. Results: The control group and the intervention group had higher intakes of lipids and saturated fat than recommended. For the lipid profile and atherogenic indices, no significant difference was observed between the pre- and postintervention periods. Conclusion: These results may have been due to the absence of dietary control, medication overload, intervention duration, mode of administration and dose of the supplement. Therefore, future studies on the effects of avocado oil are needed in this population to better control these variables.

El Estimador de Sensibilidad Insulínica de Punto Único (SPISE) supera a marcadores antropométricos de uso rutinario en la pesquisa de riesgo cardiometabólico asociado a obesidad: un estudio en adolescentes de la Región Metropolitana / The single Point Insulin Sensitivity Estimator (SPISE) outperforms routine anthropometric markers in the screening of obesity-related cardiometabolic risk: a study in adolescents from the Metropolitan Region

El Estimador de Sensibilidad a la Insulina de Punto Único (SPISE) es un biomarcador de sensibilidad a la insulina comparable al Índice de Matsuda. Se estima utilizando el IMC y los niveles de triglicéridos y HDL. El objetivo de este estudio fue comparar el rendimiento diagnóstico de SPISE con el de otros marcadores antropométricos de uso rutinario, como el IMC y la relación cintura | talla, en la pesquisa de insulinoresistencia (IR) y Síndrome Metabólico (MetS) en una muestra de 901 adolescentes de 11 a 16 años. En todos ellos se midió peso, talla, cintura, presión arterial, perfil lipídico, insulina y glicemia. La IR se diagnosticó con el HOMA-IR y el MetS con el criterio de Cook. Un zIMC ≥2.0 DE, un índice cintura/ talla ≥0.54 y un SPISE ≤ 5.4 fueron los puntos de corte utilizados para evaluar el rendimiento de estos marcadores en el diagnóstico de IR y MetS. No hubo diferencias por sexo en la prevalencia de obesidad, IR y MetS. Tanto en hombre como en mujeres, SPISE mostro una mejor capacidad para predecir el MetS (AUC: 0.95 y 0.89, respectivamente) e IR (AUC: 0.83 y 0.79, respectivamente) comparado con el rendimiento diagnóstico de la relación cintura | talla y el IMC-z. De igual manera, el SPISE mostro una mayor sensibilidad para identificar a los portadores de MetS e IR (96% y 75% en varones y 81% y 67% en mujeres, respectivamente). SPISE mostró una mejor capacidad para identificar el riesgo cardiometabólico asociado a la malnutrición por exceso al compararlo con otros indicadores de uso frecuente en clínica. Un índice de SPISE ≤5.4 fue un mejor predictor de MetS e IR que un IMC ≥2.0 DE y una relación cintura | talla ≥0.54.

The Single Point Insulin Sensitivity Estimator (SPISE) is a biomarker of insulin sensitivity comparable to the Matsuda Index. It is estimated using data on BMI, TG, and HDL. We aim to compare the diagnostic performance of SPISE with other routinely used anthropometric markers, such as BMI and waist-to-height ratio, in diagnosing insulin resistance (IR) and Metabolic Syndrome (MetS) in adolescents from 11 to 16 years. Weight, height, waist, blood pressure, lipid profile, insulin, and glycemia were measured. IR was diagnosed with the HOMA-IR and the MetS with the Cook criteria. A BMIz ≥2.0 SD, a waist-to-height ratio ≥0.54, and a SPISE ≤ 5.4 were the cut-off points used for diagnosing IR and MetS. There were no sex differences in the prevalence of obesity, IR, and MetS. In both males and females, SPISE showed a better ability to predict MetS (AUC: 0.95 and 0.89, respectively) and IR (AUC: 0.83 and 0.79, respectively) compared to the waist-to-height ratio and BMI-z. Similarly, SPISE showed greater sensitivity to identify adolescents with MetS and IR (96% and 75% in men and 81% and 67% in women, respectively) than the waist-to-height ratio and BMI-z. SPISE performed better in identifying obesity-related cardiometabolic risk than other frequently used clinical indicators. A SPISE index ≤5.4 was a better predictor of MetS and RI than a BMI ≥2.0 SD and a waist-to-height ratio ≥0.54.

Associação entre síndrome metabólica e rigidez arterial / Association between metabolic syndrome and arterial stiffness

Introdução: A síndrome metabólica (SM) é considerada um importante fator de risco para doenças cardiovasculares por promover mudanças biomecânicas nas paredes dos vasos que acarretam rigidez arterial (RA). Objetivo: Analisar a associação entre a síndrome metabólica e rigidez arterial. Além de descrever a população de estudo segundo características sociodemográficas e clínicas. Métodos: Estudos transversal de base populacional, na área restrita do Vale do Ogunjá, Salvador-Bahia. Foram obtidos dados sociodemográficos, por meio de questionário e dados clínicos. A VOP foi avaliada por tonometria de aplanação com o aparelho SphygmoCor® (AtCor Medical Pty Ltd, New South Wales, Austrália). Foram obtidas medidas de frequência e descritivas de central e dispersão, e o teste Qui-quadrado para análise estatística. Resultados: A VOP alterada foi mais prevalente em indivíduos que foram diagnosticados com a síndrome metabólica (37,2%), com uma razão de prevalência 2,0 vezes maiores quando comparados aos indivíduos hígidos (IC95%: 0,86 ­ 4,45). Houve também maior prevalência da RA no sexo masculino (30,4%), na faixa etária entre 40 a 74 anos (38,7%), em autodeclarados preto/pardo (27,4%), em divorciados/viúvos (38,9%) e com baixo nível de escolaridade (38,5%). As diferenças proporcionais entre os indivíduos com e sem rigidez arterial foram estatisticamente significantes entre as variáveis escolaridade (p=0,022), faixa etária (p=0,001) e hipertensão arterial (p=0,000). Por outro lado, não foram encontradas diferenças proporcionais estatisticamente significantes (p>0,05) entre as variáveis sexo, cor e estado civil, assim como para a síndrome metabólica e as variáveis que fazem parte da sua definição (hipertrigliceridemia, HDL, glicemia de jejum e obesidade abdominal), com exceção da hipertensão arterial. Conclusão: Apesar da maior prevalência de rigidez arterial em indivíduos com síndrome metabólica, não foi encontrada uma associação estatisticamente significante entre essas duas variáveis. Foi possível verificar uma associação estatisticamente significante entre a hipertensão arterial, indivíduos com idade mais avançada e com baixo nível de escolaridade e a rigidez arterial. (AU)

iomechanical changes in the walls of the vessels that cause arterial stiffness (AR). Objetive: Analyze the association between Metabolic Syndrome (MS) and arterial stiffness and to characterize the study population according to sociodemographic and clinical characteristics. Methods: Cross-sectional population-based studies, in the restricted area of Vale do Ogunjá, Salvador-Bahia. Sociodemographic data, through questionnaire and clinical data were obtained. A PWV was evaluated by applanation tonometry using the device SphygmoCor® (AtCor Medical Pty Ltd, New South Wales, Australia). Frequency and descriptive measurements of central and dispersion were obtained, and the Chi-square test to statistical analysis. Results: The altered PWV was more prevalent in individuals who were diagnosed with the metabolic syndrome (37.2%), with a prevalence ratio 2.0 times higher when compared to healthy individuals (95% CI: 0.86 - 4.45). There was also a higher prevalence of AR in males (30.4%), aged between 40 and 74 years (38.7%), in self-declared black / brown (27.4%), in divorced / widowed (38, 9%) and with a low level of education (38.5%). The proportional differences between individuals with and without arterial stiffness were statistically significant between the variables education (p = 0.022), age group (p = 0.001) and arterial hypertension (p = 0.000). On the other hand, there were no statistically significant proportional differences (p> 0.05) between the variables gender, color and marital status, as well as for the metabolic syndrome and the variables that are part of its definition (hypertriglyceridemia, HDL, blood glucose) fasting and abdominal obesity), with the exception of arterial hypertension. Conclusion: Despite the higher prevalence of arterial stiffness in individuals with metabolic syndrome, no statistically significant association was found between these two variables. It was possible to verify a statistically significant association between arterial hypertension, individuals with older age and with low level of education and arterial stiffness.

Trajetória do crescimento e composição corporal das crianças nascidas menores que 32 semanas de idade gestacional ou com peso inferior a 1500 gramas até 4 a 7 anos de idade: estudo de coorte / Growth trajectory and body composition of children born under 32 weeks gestational age or weighing less than 1500 g until 4 to 7 years of age: a cohort study

Introdução: Os recém-nascidos muito pré-termo e com muito baixo peso, apresentam na idade corrigida do termo, uma menor massa livre de gordura e maior adiposidade, em relação aos nascidos a termo. O aumento da gordura corporal na idade corrigida do termo pode ser fisiológico devido a uma adaptação do recém-nascido pré-termo a vida extrauterina. Entretanto, o déficit de massa livre de gordura pode persistir ao longo da vida e reflete uma capacidade metabólica reduzida e, portanto, o maior risco de doenças metabólicas no futuro. Os estudos sobre a composição corporal na idade pré-escolar e escolar de crianças nascidas pré-termo evidenciam resultados conflitantes na literatura. Objetivo: O objetivo deste estudo foi avaliar a composição corporal e o crescimento de crianças nascidas muito pré-termo ou muito baixo peso, entre 4 e 7 anos. Esta pesquisa apresenta como objetivos específicos comparar a composição corporal e o crescimento entre crianças que nasceram pequenas e adequadas para idade gestacional e avaliar associações entre a composição corporal nos primeiros 3 meses de vida com a massa livre de gordura e percentual de gordura entre 4 e 7 anos. Métodos: Estudo de coorte de recém-nascidos menores de 32 semanas de idade gestacional ou peso inferior a 1500 g, no Instituto Nacional em Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira/Fiocruz. Os dados antropométricos e da composição corporal, com o uso da pletismografia por deslocamento de ar, foram coletados nas idades corrigidas do termo e 3 meses, e na idade entre 4 e 7 anos. O teste t de Student e o teste qui-quadrado foram utilizados para comparar o crescimento e a composição corporal entre recém-nascidos pequenos, e adequados para idade gestacional, nas idades corrigidas do termo e 3 meses e na idade entre 4 e 7 anos. A análise de regressão linear múltipla foi realizada para avaliar as associações entre a composição corporal e o sexo masculino nos primeiros 3 meses de vida com a massa livre de gordura e o percentual de gordura na idade entre 4 e 7 anos. Para todas as análises foi considerado o nível de significância de 0,05. Resultados: Os recém-nascidos muito pré-termo, pequenos para idade gestacional, na idade corrigida do termo, apresentaram menor massa livre de gordura e massa de gordura (gramas, percentual e índices) e menor peso, comprimento e perímetro cefálico do que os nascidos adequados para idade gestacional. Aos 3 meses, a massa livre de gordura, índice de massa livre de gordura, peso e comprimento permaneceram menores no grupo dos nascidos pequenos para idade gestacional. Entre 4 e 7 anos a composição corporal e a antropometria foram similares entre os grupos. Na idade corrigida do termo, a massa livre de gordura apresentou associação positiva, e o percentual de gordura associação negativa com a massa livre de gordura aos 4 a 7 anos de idade. Aos 3 meses, a massa livre de gordura apresentou associação positiva com a massa livre de gordura na idade de 4 a 7 anos. O ganho de massa livre de gordura entre o período do termo e 3 meses também apresentou associação positiva com a massa livre de gordura aos 4 a 7 anos de idade. Conclusão: As diferenças na composição corporal observadas nos primeiros 3 meses de vida entre as crianças nascidas pré-termo pequenas e adequadas para idade gestacional, não se mantiveram entre 4 e 7 anos. A composição corporal na idade de 4 a 7 anos, apresentou associações com a massa livre de gordura nos primeiros 3 meses de idade corrigida, sendo este um período sensível para o risco de doenças metabólicas ao longo da vida. Os estudos longitudinais de longo prazo são necessários para melhor avaliar a trajetória da qualidade do crescimento das crianças nascidas muito pré-termo.

Introduction: Very preterm and very low birth weight infants have less fat-free mass and higher adiposity at term corrected age, than those born at term. The increase in fat mass may be physiological due to an adaptation of the preterm newborn to extrauterine life. However, the deficit of fat-free mass may persist throughout life and reflects a reduced metabolic capacity and therefore, increasing the risk of metabolic diseases in the future. Studies on body composition at preschool and school ages of children born preterm show conflicting results in the literature. Objective: The aim of the present study was to evaluate the body composition and growth of children born very preterm and/or very low birth weight, between 4 and 7 years of age. This research presents as specific objectives the comparison of body composition and growth between children born small and adequate for gestational age and to evaluate associations between body composition in the first 3 months of life with fat-free mass and fat percentage between 4 and 7 years of age. Methods: Cohort study of infants younger than 32 weeks of gestational age or less than 1500 g, at the Instituto Nacional em Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira / Fiocruz. Anthropometric and body composition data, using air displacement plethysmography, were collected at term and 3-month corrected ages, and at 4 to 7 years of age. Student's t test and chi-square test were used to compare growth and body composition between small and appropriate for gestational age infants at term and 3-month corrected ages, and at 4 to 7 years of age. A multiple linear regression analysis was performed to evaluate the associations between body composition and male sex in the first 3 months of life with fat-free mass and fat percentage at 4 to 7 years of age. For all analyses, a significance level of 0.05 was considered. Results: The very preterm, small for gestational age infants had had lower fat-free mass and fat mass (grams, percentual and indexes), and lower weight, length, and head circumference than the appropriate for gestational age infants. At 3 months, fat-free mass, fat-free mass index, weight and length remained lower in the small for gestational age group. Between 4 and 7 years, body composition and anthropometry were similar between the groups. At term corrected age, the fat-free mass showed a positive association and the percentage of fat mass a negative association with fat-free mass at 4 to 7 years. At 3 months, fat-free mass showed a positive association with fat-free mass at ages 4 to 7 years. Also, the gain in fat-free mass between term to 3 months was positively associated with fat-free mass ate 4 to 7 years at age. Conclusion: The differences in body composition and anthropometry observed in the first 3 months of life between children born very preterm small and appropriate for gestational age, were not maintained at 4 to 7 years of age. Body composition at preschool and school age shows associations with fat-free mass and % fat mass in the first 3 months of corrected age, and this is a sensitive period for the risk of metabolic diseases. Long-term longitudinal studies are needed to better assess the trajectory of growth quality in children born very preterm.

Prevalência e fatores associados à síndrome metabólica em idosos atendidos na atenção primária em saúde / Prevalence and factors associated with metabolic syndrome in elderly attended in primary health care / Prevalencia y factores asociados al síndrome metabólico en el cuidado del anciano en la atención primaria de salud

Objetivo: avaliar a prevalência de síndrome metabólica e sua associação com variáveis sociodemográficas, clínicas, antropométricas e estilo de vida em idosos atendidos na atenção primária. Método: estudo transversal realizado com 344 idosos em uma Unidade Básica de Saúde do Distrito Federal. Realizaram-se análises do perfil lipídico, glicemia de jejum e hemoglobina glicada. Foram avaliados dados sociodemográficos, hábitos de vida, pressão arterial, antropometria e percentual de gordura. Realizou-se regressão de Poisson para cálculo da razão de prevalência bruta e ajustada. Resultados: a prevalência de síndrome metabólica foi de 62,2%. A hipertensão arterial (RPajustada=1,31; IC95%=1,02-1,67), cintura aumentada (RPajustada=1,46; IC95%=1,21-1,76), hipertrigliceridemia (RPajustada=1,98; IC95%=1,67-2,34) e HDL diminuído (RPajustada=1,19; IC95%=1,03-1,37) foram significativamente associados à síndrome metabólica. Conclusão: a elevada prevalência de síndrome metabólica e sua associação com fatores modificáveis apontam para a necessidade de identificar e controlar precocemente os fatores de risco em idosos

Objective: to evaluate the prevalence of metabolic syndrome and association with sociodemographic, clinical, anthropometric and lifestyle variables in elderly people attended in primary care. Method: cross-sectional study carried out with 344 elderly in a Basic Health Unit in the Federal District. Analyzes of lipid profile, fasting glucose and glycated hemoglobin were performed. Sociodemographic data, lifestyle habits, blood pressure, anthropometry and fat percentage were evaluated. Poisson regression was performed to calculate the crude and adjusted prevalence ratio. Results: the prevalence of metabolic syndrome was 62.2%. The arterial hypertension (PRadjusted =1.31; 95%CI=1.02-1.67), increased waistline (PRadjusted=1.46; 95%CI=1.21-1.76), hypertriglyceridemia (PRadjusted=1.98; 95%CI=1.67-2.34) and decreased HDL (PRadjusted=1.19; 95%CI=1.03-1.37) were significantly associated with metabolic syndrome. Conclusion: the high prevalence of metabolic syndrome and association with modifiable factors point to the need to early identify and control risk factors in the elderly

Objetivo: evaluar la prevalencia del síndrome metabólico y su asociación con variables sociodemográficas, clínicas, antropométricas y de estilo de vida en ancianos atendidos en atención primaria. Método: estudio transversal realizado con 344 ancianos en una Unidad Básica de Salud del Distrito Federal. Se realizaron análisis del perfil lipídico, glucosa en ayunas y hemoglobina glucosilada. Se evaluaron datos sociodemográficos, hábitos de vida, presión arterial, antropometría y porcentaje de grasa. Se realizó regresión de Poisson para calcular la razón de prevalencia cruda y ajustada. Resultados: la prevalencia de síndrome metabólico fue del 62,2%. Hipertensión arterial (RPajustada=1,31; IC95%=1,02-1,67), aumento de cintura (RPajustada=1,46; IC95%=1,21-1,76), hipertrigliceridemia (RPajustada=1,98; IC95%=1,67-2,34) y la disminución de HDL (RPajustada= 1,19; IC del 95 % = 1,03-1,37) se asoció significativamente con el síndrome metabólico. Conclusión: la alta prevalencia del síndrome metabólico y su asociación con factores modificables apuntan a la necesidad de identificar y controlar precozmente los factores de riesgo en los ancianos

Factores del síndrome metabólico en el riesgo cardiovascular en pobladores peruanos / Factors of Metabolic Syndrome in Cardiovascular Risk among Peruvian Populations

Objetivo: Determinar la incidencia de los factores del síndrome metabólico en el riesgo cardiovascular en pobladores del distrito de Ayacucho en Perú. Método: Enfoque cuantitativo, diseño correlacional causal. La muestra fue de 140 pobladores mayores de 18 años a quienes se les realizó el dosaje serológico y se tomaron las medidas antropométricas necesarias mediante el uso de equipos biomédicos calibrados y específicos para cada parámetro. Se utilizó como instrumento la Tabla de cálculo de Síndrome Metabólico (ALAD) y la tabla de Framinghan. Resultados: Se determinó que el Síndrome Metabólico incide significativamente (0,000) en el Riesgo Cardiovascular con un J2= 15,432 (1) y una influencia de 16,8 por ciento enfatizado por el coeficiente de Pseudo-R2 Nagelkerke. Conclusión: Se concluye que el síndrome metabólico incide en el riesgo cardiovascular de los pobladores evaluados, debido a que presentaron niveles bajo de colesterol HDL, triglicéridos altos, un incremento de perímetro abdominal y hábitos de fumar, siendo estos factores determinantes para incrementar el riesgo cardiovascular (AU)

Objective: To determine the incidence of metabolic syndrome factors on cardiovascular risk in inhabitants of the district of Ayacucho in Peru. Methods: Quantitative approach, causal correlational design. The sample consisted of 140 inhabitants over 18 years of age who underwent serological dosage and the necessary anthropometric measurements were taken using calibrated and specific biomedical equipment for each parameter. The Metabolic Syndrome Calculation Table (ALAD) and the Framinghan table were used as instruments. Results: It was determined that the Metabolic Syndrome has a significant influence (0.000) on Cardiovascular Risk with a J2= 15.432 (1) and an influence of 16.8 percent emphasized by the Pseudo-R2 Nagelkerke coefficient. Conclusion: It is concluded that the metabolic syndrome has an impact on the cardiovascular risk of the population evaluated, because they presented low HDL cholesterol levels, high triglycerides, an increase in abdominal perimeter and smoking habits, these being determining factors to increase cardiovascular risk(AU)